Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities from Discontinued Operations (2017 - 2023)

Lifecore Biomedical, Inc. \De\ (LFCR) has 4 years of Liabilities from Discontinued Operations data on record, last reported at 518000.0 in Q1 2023.

For Q1 2023, Liabilities from Discontinued Operations changed N/A year-over-year to 518000.0; the TTM value through Feb 2023 reached 518000.0, changed N/A, while the annual FY2021 figure was 3981000.0, N/A changed from the prior year.
Liabilities from Discontinued Operations reached 518000.0 in Q1 2023 per LFCR's latest filing, down from 3981000.0 in the prior quarter.
Across five years, Liabilities from Discontinued Operations topped out at 7240000.0 in Q1 2021 and bottomed at 518000.0 in Q1 2023.